XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer

Title
XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer
Authors
Keywords
-
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 61, Issue 13, Pages 1193-1202
Publisher
Elsevier BV
Online
2009-08-13
DOI
10.1016/j.addr.2009.01.007

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started